戴岚

戴岚 is a declared insider of 毕得医药 (board member), with filings sourced from SSE / SZSE (CSRC). Over a trading history stretching from 9 October 2023 to 5 November 2026, the count stands at 7 filings.

In open-market terms, that means 2 purchases worth €141k on one side and 5 sales worth €2.2M on the other. Netting one side against the other leaves €2.1M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show no purchases and 4 sales.

On 5 November 2026 came the latest disclosure, an open-market sale for €800k in 毕得医药. The clock since the last published purchase (26 March 2024) now reads 957 days. The median gap between trade and publication is zero days: most filings appear on the same day. Until a filing is published, the market cannot know about the trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.